Meta Biomed Co., Ltd. (KOSDAQ: 059210)
South Korea
· Delayed Price · Currency is KRW
3,545.00
-120.00 (-3.27%)
Dec 20, 2024, 9:00 AM KST
Meta Biomed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 15,343 | 10,080 | 2,628 | 9,522 | -4,093 | 3,346 | Upgrade
|
Depreciation & Amortization | 4,657 | 4,223 | 3,860 | 3,571 | 3,941 | 3,713 | Upgrade
|
Loss (Gain) From Sale of Assets | 31.24 | -12.62 | -1,212 | -1,160 | 95.87 | 2.83 | Upgrade
|
Asset Writedown & Restructuring Costs | 1,015 | 1,015 | 487.37 | 541.23 | 4,661 | 123.63 | Upgrade
|
Loss (Gain) From Sale of Investments | -392.66 | -90.29 | -53.65 | -51.16 | 260.6 | 18.79 | Upgrade
|
Loss (Gain) on Equity Investments | -784.83 | -682.88 | -373.09 | -537.62 | -468.69 | -392.13 | Upgrade
|
Provision & Write-off of Bad Debts | -246.57 | -158.44 | -172.39 | -1,376 | 8.39 | 178.85 | Upgrade
|
Other Operating Activities | -4,132 | -2,926 | 2,115 | -1,637 | 57.12 | 945.21 | Upgrade
|
Change in Accounts Receivable | 907.41 | 186.61 | -1,024 | -171.24 | 2,190 | -2,183 | Upgrade
|
Change in Inventory | 2,112 | -470.44 | 926.99 | 2,038 | -1,989 | -2,204 | Upgrade
|
Change in Accounts Payable | -1,015 | 304.05 | 93.14 | -1,503 | -513.05 | 93.06 | Upgrade
|
Change in Other Net Operating Assets | 417.74 | -1,251 | 1,884 | 1,900 | 712 | -778.86 | Upgrade
|
Operating Cash Flow | 17,912 | 10,217 | 9,159 | 11,136 | 4,862 | 2,865 | Upgrade
|
Operating Cash Flow Growth | 85.96% | 11.55% | -17.75% | 129.05% | 69.70% | - | Upgrade
|
Capital Expenditures | -11,876 | -11,489 | -15,395 | -2,067 | -2,227 | -7,561 | Upgrade
|
Sale of Property, Plant & Equipment | 3.74 | 128.06 | 7.45 | 1,413 | 6.53 | 0.54 | Upgrade
|
Cash Acquisitions | - | - | -2,295 | -2.45 | - | - | Upgrade
|
Divestitures | - | - | - | 535.01 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -188.79 | -5.43 | 85.95 | -33.29 | -824.5 | -508.03 | Upgrade
|
Investment in Securities | -26,968 | 1,116 | -167.9 | 6,349 | -7,464 | 223.18 | Upgrade
|
Other Investing Activities | 96.4 | -1,451 | 3,186 | 130 | 593.94 | 1,118 | Upgrade
|
Investing Cash Flow | -38,932 | -11,701 | -14,578 | 6,324 | -9,915 | -6,727 | Upgrade
|
Long-Term Debt Issued | - | 11,375 | 37,083 | 1,949 | 16,759 | 7,357 | Upgrade
|
Long-Term Debt Repaid | - | -11,940 | -27,828 | -17,827 | -5,123 | -6,318 | Upgrade
|
Net Debt Issued (Repaid) | 25,222 | -565.37 | 9,255 | -15,878 | 11,635 | 1,040 | Upgrade
|
Repurchase of Common Stock | - | - | -63.26 | - | - | -132.12 | Upgrade
|
Dividends Paid | -457.42 | -457.42 | -458.02 | -229.01 | -232.67 | -233.28 | Upgrade
|
Other Financing Activities | -168 | -0 | - | 0 | 0 | - | Upgrade
|
Financing Cash Flow | 24,597 | -1,023 | 8,734 | -16,107 | 11,403 | 674.26 | Upgrade
|
Foreign Exchange Rate Adjustments | -93.57 | 77.02 | -201.36 | 121.38 | -60.48 | 50.35 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | -0 | 0 | - | - | Upgrade
|
Net Cash Flow | 3,482 | -2,430 | 3,113 | 1,474 | 6,288 | -3,138 | Upgrade
|
Free Cash Flow | 6,036 | -1,271 | -6,236 | 9,069 | 2,634 | -4,696 | Upgrade
|
Free Cash Flow Growth | - | - | - | 244.28% | - | - | Upgrade
|
Free Cash Flow Margin | 6.54% | -1.53% | -9.04% | 15.43% | 5.85% | -7.91% | Upgrade
|
Free Cash Flow Per Share | 168.84 | -55.59 | -272.48 | 396.00 | 114.32 | -201.62 | Upgrade
|
Cash Interest Paid | 2,158 | 2,176 | 1,259 | 733.31 | 1,278 | 1,017 | Upgrade
|
Cash Income Tax Paid | 75.69 | 80 | 379.03 | 357.43 | 293.62 | -42.04 | Upgrade
|
Levered Free Cash Flow | 9,704 | -3,338 | -6,175 | 5,650 | 1,895 | -4,182 | Upgrade
|
Unlevered Free Cash Flow | 11,771 | -1,891 | -5,306 | 6,366 | 2,527 | -3,438 | Upgrade
|
Change in Net Working Capital | -11,694 | 1,246 | -2,790 | -1,607 | -66.21 | 2,678 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.